These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24384116)

  • 21. [Sterile inflammatory response to ischemia-reperfusion injury: immediate and long term consequences on graft function].
    Thaunat O
    Bull Acad Natl Med; 2011; 195(4-5):847-59; discussion 859. PubMed ID: 22375356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia.
    Lehmann TG; Koeppel TA; Münch S; Heger M; Kirschfink M; Klar E; Post S
    Microvasc Res; 2001 Nov; 62(3):284-92. PubMed ID: 11678631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic potential of complement inhibitors in myocardial ischaemia.
    Lucchesi BR; Tanhehco EJ
    Expert Opin Investig Drugs; 2000 May; 9(5):975-91. PubMed ID: 11060721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between coagulation and complement--their role in inflammation.
    Oikonomopoulou K; Ricklin D; Ward PA; Lambris JD
    Semin Immunopathol; 2012 Jan; 34(1):151-65. PubMed ID: 21811895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for
    Delaura IF; Gao Q; Anwar IJ; Abraham N; Kahan R; Hartwig MG; Barbas AS
    Front Immunol; 2022; 13():1000172. PubMed ID: 36341433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of C1-INH on ischemia/reperfusion injury in a porcine limb ex vivo perfusion model.
    Abdelhafez MM; Shaw J; Sutter D; Schnider J; Banz Y; Jenni H; Voegelin E; Constantinescu MA; Rieben R
    Mol Immunol; 2017 Aug; 88():116-124. PubMed ID: 28641140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
    He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
    J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement and its implications in cardiac ischemia/reperfusion: strategies to inhibit complement.
    Monsinjon T; Richard V; Fontaine M
    Fundam Clin Pharmacol; 2001 Oct; 15(5):293-306. PubMed ID: 11903498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimeric tyrosine sulfate acts as an endothelial cell protectant and prevents complement activation in xenotransplantation models.
    Laumonier T; Walpen AJ; Matozan KM; Korchagina EY; Bovin NV; Haeberli A; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 May; 11(3):262-8. PubMed ID: 15099206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local and remote ischemia-reperfusion injury is mitigated in mice overexpressing human C1 inhibitor.
    Inderbitzin D; Beldi G; Avital I; Vinci G; Candinas D
    Eur Surg Res; 2004; 36(3):142-7. PubMed ID: 15178902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement in ischemia reperfusion injury.
    Riedemann NC; Ward PA
    Am J Pathol; 2003 Feb; 162(2):363-7. PubMed ID: 12547694
    [No Abstract]   [Full Text] [Related]  

  • 33. The pivotal role of the mentor in triggering the research on Complement system.
    Castellano G
    Mol Immunol; 2015 Nov; 68(1):25-6. PubMed ID: 26597200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the complement system.
    Marsh JE; Pratt JR; Sacks SH
    Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):557-62. PubMed ID: 10541217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies for targeting complement inhibitors in ischaemia/reperfusion injury.
    Dong J; Pratt JR; Smith RA; Dodd I; Sacks SH
    Mol Immunol; 1999; 36(13-14):957-63. PubMed ID: 10698350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of C1 inhibitor on intestinal ischemia and reperfusion injury.
    Lu F; Chauhan AK; Fernandes SM; Walsh MT; Wagner DD; Davis AE
    Am J Physiol Gastrointest Liver Physiol; 2008 Nov; 295(5):G1042-9. PubMed ID: 18787060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complement cascade in kidney disease: from sideline to center stage.
    McCaughan JA; O'Rourke DM; Courtney AE
    Am J Kidney Dis; 2013 Sep; 62(3):604-14. PubMed ID: 23489674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of polyclonal anti-thymocyte globulins on the expression of adhesion and inflammation molecules after ischemia-reperfusion injury.
    Beiras-Fernandez A; Chappell D; Hammer C; Beiras A; Reichart B; Thein E
    Transpl Immunol; 2009 Mar; 20(4):224-8. PubMed ID: 19041395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The emerging role of complement inhibitors in transplantation.
    Frémeaux-Bacchi V; Legendre CM
    Kidney Int; 2015 Nov; 88(5):967-73. PubMed ID: 26376132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.